Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
34 hedge funds and large institutions have $189M invested in Calithera Biosciences, Inc in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$36.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.6M |
| 4 |
Jennison Associates
New York
|
+$9.64M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.76M |
Top Sellers
CALA Hedge Fund Activity: Q4 2014 in Review
34 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2014, worth a combined $189M.
Buyers outnumbered sellers: 34 funds opened new CALA positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $36.1M.
- 34 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $189M of Calithera Biosciences, Inc stock for Q4 2014.
- 34 funds opened new Calithera Biosciences, Inc positions in Q4 2014 and 0 closed out, a net change of +34 holders.
- The largest Calithera Biosciences, Inc buyer in Q4 2014 was Adage Capital Partners, an estimated $36.1M added.
Based on aggregated 13F filings for Q4 2014.